Why do so many clinical trials of therapies for Alzheimer's disease fail?

被引:158
|
作者
Anderson, Roy M. [1 ]
Hadjichrysanthou, Christoforos [1 ]
Evans, Stephanie [1 ]
Wong, Mei Mei [1 ]
机构
[1] Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London W2 1PG, England
来源
LANCET | 2017年 / 390卷 / 10110期
关键词
D O I
10.1016/S0140-6736(17)32399-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2327 / 2329
页数:3
相关论文
共 50 条
  • [1] Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
    Ratziu, Vlad
    Friedman, Scott L.
    [J]. GASTROENTEROLOGY, 2023, 165 (01) : 5 - 10
  • [2] Clinical trial research in focus: why do so many clinical trials fail in IPF?
    Spagnolo, Paolo
    Maher, Toby M.
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (05): : 372 - 374
  • [3] Why do so many trials of vitamin D supplementation fail?
    Boucher, Barbara J.
    [J]. ENDOCRINE CONNECTIONS, 2020, 9 (09): : R195 - R206
  • [4] WHY DO CLINICAL TRIALS OF LIPID MODIFYING THERAPIES FAIL?
    Nicholls, S.
    [J]. HYPERTENSION, 2014, 63 (06) : E165 - E165
  • [5] Why Do So Many Drugs for Alzheimer's Disease Fail in Development? Time for New Methods and New Practices?
    Becker, Robert E.
    Greig, Nigel H.
    Giacobini, Ezio
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2008, 15 (02) : 303 - 325
  • [6] Why do clinical trials fail?
    Rickels, Karl
    Robinson, Donald S.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (04) : 420 - 421
  • [7] WHY DO SO MANY REUSE PROGRAMS FAIL
    CARD, D
    COMER, E
    [J]. IEEE SOFTWARE, 1994, 11 (05) : 114 - 115
  • [8] Why do so many industrial collaborations fail?
    Leslie, A.
    [J]. Engineering Management, 2006, 16 (02): : 40 - 42
  • [9] Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?
    Franco, Rafael
    Cedazo-Minguez, Angel
    [J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [10] Why Do Phase III Clinical Trials in Oncology Fail so Often?
    Amiri-Kordestani, Laleh
    Fojo, Tito
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (08) : 568 - 569